Armata Pharmaceuticals (ARMP) Price to Sales (2013 - 2020)

Armata Pharmaceuticals has disclosed Price to Sales across 6 years of filings, most recently posting 2357.25 for Q2 2020.

• In Q2 2020, Price to Sales changed N/A year-over-year to 2357.25; the TTM figure through Jun 2020 stood at 624.57 (changed N/A YoY), while the FY2017 annual figure was 56.1, up 236.93% from the prior year.
• Price to Sales came in at 2357.25 for Q2 2020 at Armata Pharmaceuticals, up from 322.57 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 2357.25 in Q2 2020 to a low of 131.54 in Q2 2016.
• Average Price to Sales over 3 years is 492.31, with a median of 223.33 recorded in 2017.
• The largest YoY upside for Price to Sales was 258.65% in 2016 against a maximum downside of 75.58% in 2016.
• Over 3 years, Price to Sales stood at 196.77 in 2016, then surged by 63.93% to 322.57 in 2017, then surged by 630.77% to 2357.25 in 2020.
• Per Business Quant data, the three most recent Price to Sales figures were 2357.25 in Q2 2020, 322.57 in Q4 2017, and 223.33 in Q3 2017.